RESUMEN
The new Cuban chondrite, Viñales, fell on February first, 2019 at Pinar del Rio, northwest of Cuba (22°37'10â³N, 83°44'34â³W). A total of about 50-100 kg of the meteorite were collected and the masses of individual samples are in a range 2-1100 g. Two polished thin sections were studied by optical microscope, Raman spectroscopy and electron microprobe analysis in this study. The meteorite mainly consists of olivine (Fa24.6), low-Ca pyroxene (Fs20.5), and troilite and Fe-Ni metal, with minor amounts of feldspar (Ab82.4-84.7). Three poorly metamorphosed porphyritic olivine-pyroxene and barred olivine chondrules are observed. The homogeneous chemical compositions and petrographic textures indicate that Viñales is a L6 chondrite. The Viñales has fresh black fusion crust with layered structure, indicating it experienced a high temperature of â¼1650°C during atmospheric entry. Black shock melt veins with width of 100-600 µm are pervasive in the Viñales and olivine, bronzite, and metal phases are dominate minerals of the shock melt vein. The shock features of major silicate minerals suggest a shock stage S3, partly S4, and the shock pressure could be >10 GPa.
Asunto(s)
Meteoroides , Cuba , Minerales/análisis , Minerales/química , Espectrometría RamanRESUMEN
RNA interference (RNAi) is demonstrated as one of the most powerful technologies for sequence-specific suppression of genes in disease therapeutics. Exploration of novel vehicles for small interfering RNA (siRNA) delivery with high efficiency, low cytotoxicity, and self-monitoring functionality is persistently pursued. Herein, by taking advantage of aggregation-induced emission luminogen (AIEgen), we developed a novel class of Ag@AIE core@shell nanocarriers with regulable and uniform morphology. It presented excellent efficiencies in siRNA delivery, target gene knockdown, and cancer cell inhibition in vitro. What's more, an anticancer efficacy up to 75% was achieved in small animal experiments without obvious toxicity. Attributing to the unique AIE properties, real-time intracellular tracking of siRNA delivery and long-term tumor tissue imaging were successfully realized. Compared to the commercial transfection reagents, significant improvements were obtained in biocompatibility, delivery efficiency, and reproducibility, representing a promising future of this nanocarrier in RNAi-related cancer therapeutics.